Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±¹¼ÒÀû ½Äµµ¾ÏÀÇ º¹ÇÕÄ¡·á ½Ã ¿¹ÈÄ ÀÎÀڷμ­ p53´Ü¹é°ú ¹ßÇöÀÌ ¿ÏÀü ¹ÝÀÀ°ú »ýÁ¸¿¡ ¹ÌÄ¡´Â ¿µÇâ The Prognostic Significance of the p53 Overexpression on Complete Response and Survival in Preoperative Chemoradiotherapy Treated Squamous Cell Esophageal Carcinoma

´ëÇѾÏÇÐȸÁö 1998³â 30±Ç 2È£ p.278 ~ 287
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼º¹è ±è»óÈñ/Á¤ÈÆ¿ë/ÀÌÇå°æ/°­°æÈÆ/±èÁ¾ÈÆ/¼ÛÈ£¿µ/¹Ú½ÂÀÏ/±èµ¿°ü

Abstract

°á·Ð
º¹ÇÕ Ä¡·á¸¦ ½ÃÇàÇÑ ±¹¼ÒÀû ½Äµµ¾Ï ȯÀÚ 42¿¹ Áß 27¿¹¿¡¼­ p53 ´Ü¹é °ú¹ßÇöÀ» º¸¿© p53
´Ü¹é °ú¹ßÇöÀ²Àº 64.2%¿´À¸¸ç, P53 ´Ü¹é ºñ¹ßÇöÀÏ °æ¿ì p53 ´Ü¹é °ú¹ßÇö±º¿¡ ºñÇØ Á¶Á÷ÇÐ
Àû ¿ÏÀü ¹ÝÀÀ ȹµæÀ²ÀÌ ºñ±³Àû ³ô°í, »ýÁ¸±â°£ÀÇ ¿¬Àå ¹× Áúº´ ¹«ÁøÇ༺ »ýÁ¸±â°£
(progression free duration)ÀÇ Áõ°¡°æÇâÀ» º¸À̳ª, Åë°èÀûÀÎ À¯ÀÇÇÑ Â÷ÀÌ´Â ¾ø¾ú´Ù. ÇâÈÄ ´õ
¸¹Àº ±¹¼ÒÀû ½Äµµ¾Ï ³»½Ã°æ »ý°Ë Á¶Á÷¿¡¼­ p53À¯ÀüÀÚ º¯ÀÌ¿¡ ´ëÇÑ °Ë»öÀ» ÅëÇØ ½Äµµ¾Ï¿¡¼­
p53À¯ÀüÀÚÀÇ ¿ªÇÒÀ» ±Ô¸íÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î »ç·áµÈ´Ù.

Purpose : To determine the frequency of p53 overexpression and to analyse the
relationship between p53 overexpression and complete response rate, survival in
locoregionl squamous cell esophageal cancers treated with preoperative chemoradiation
multimodality approaches.
Materials and Methods : Using a microwave oven heating method, we have detected
p53 overexpression by immunohistochemically with a monoclonal antibody(DO-7) in
formalin-fixed paraffin-embedded samples of 42 patients with locoregional squamous cell
esophageal cancer, who treated with concurrent chemotherapy and radiation followed by
surgery.
Results : In 27 of 42 tumors(64.2%), nuclear immunoreactivity for the p53 protein was
detected. Complete response rate, evaluated in surgical specimen 3-4 weeks after
chromo-radiation seemed to be high in p53 positive group compared to p53 negative
group, however, there was no statistically significant difference in acquiring better
complete response rate, overall survival and progression free survival between p53
positive and p53 negative group(p=0.0546, p=0.0599, p=0.6832). Complete response
group(n=17) survived longer than non-complete response group(n=25)(p=0.0010).
Conclusion : The results indicate that p53 is not a statistically significant prognostic
factor in obtaining better complete response rate, overall survival and progression free
survival of the patients with esophageal carcinoma treated with preoperative
chemoradiotherapy. Additional studies are warranted for further evaluation.

Å°¿öµå

p53 overexpression; Esophageal cancer; Immunohistochemistry; Prognostic factor;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS